# Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

> **NCT03543189** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 44 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Disease

## Interventions

- **DRUG:** Nivolumab
- **RADIATION:** Brachytherapy
- **RADIATION:** External Beam Radiation Therapy
- **DRUG:** Androgen Deprivation Therapy

## Key facts

- **NCT ID:** NCT03543189
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-03
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03543189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03543189, "Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03543189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*